TLR3 and alcohol abuse: A recent study on alcohol-induced liver disease (ALD) and intestinal damage, based on a chronic-binge alcohol abuse model, explored the therapeutic mechanisms of pre-activated (with toll-like receptor 3; TLR3) bone marrow-derived mesenchymal stem cells (P-BMMSCs) (29).